LauraJeanHavrileskyMD

Obstetrics & Gynecology • Durham, NC

Gynecologic Oncology

Professor of Obstetrics & Gynecology, Duke University

Join to view full profile

Dr. Havrilesky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Havrilesky's full profile

Already have an account?

Office
1000 Duke Medical Ctr
Durham, NC 27710
Phone+1 919-684-8111

Education & Training

Duke University HospitalFellowship, Gynecologic Oncology, 1999 - 2002
Duke University HospitalResidency, Obstetrics and Gynecology, 1995 - 1999
Duke University School of MedicineClass of 1995

Certifications & Licensure

NC State Medical License 1998 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients Start of enrollment: 2008 Sep 01
Completed
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 2
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 Start of enrollment: 2100 Jan 01
Not yet recruiting
Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer Start of enrollment: 2011 Nov 01
Completed
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Lymphedema in Endometrial Cancer Start of enrollment: 2013 Oct 01
Completed
The Treatment Preferences of Women Diagnosed With Ovarian Cancer Start of enrollment: 2017 Oct 19
Completed
Pain Perception During Vulvar Biopsy Start of enrollment: 2018 Sep 17
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

325 citations
Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer
Janiel M. Cragun, Laura J. Havrilesky, Brian Calingaert, Ingrid S. Synan, Angeles Alvarez Secord
Journal of Clinical Oncology. 2005-06-01
127 citations
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...
Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01
366 citations
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Evan R. Myers, Patricia G. Moorman, Jennifer M Gierisch, Laura J. Havrilesky, Lars J. Grimm
JAMA. 2015-10-20

Journal Articles

Association of Medicaid Expansion with Mortality from Gynecologic Cancers
Benjamin B Albright, Laura J Havrilesky, Emeline M Aviki, American Journal of Obstetrics and Gynecology

Lectures

Patient preferences for maintenance PARP therapy in ovarian cancer treatment.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Which Malnutrition Criteria to Use in Gynecologic Cancers?June 3rd, 2022
Birth Control Pills Tied to Lower Ovarian Cancer RiskJune 7th, 2013
The Pill Tied to Lower Ovarian Cancer RiskJune 6th, 2013

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow